The Revaluation of Plant-Derived Terpenes to Fight Antibiotic-Resistant Infections

被引:38
|
作者
Cappiello, Floriana [1 ]
Loffredo, Maria Rosa [1 ]
Del Plato, Cristina [2 ,3 ]
Cammarone, Silvia [2 ]
Casciaro, Bruno [3 ]
Quaglio, Deborah [2 ]
Mangoni, Maria Luisa [1 ]
Botta, Bruno [2 ]
Ghirga, Francesca [3 ]
机构
[1] Sapienza Univ Rome, Dept Biochem Sci, Pasteur Italia Fdn Cenci Bolognetti, Ple Aldo Moro 5, I-00185 Rome, Italy
[2] Sapienza Univ Rome, Dept Chem & Technol Drugs, Dept Excellence 2018 2022, Ple Aldo Moro 5, I-00185 Rome, Italy
[3] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Viale Regina Elena 291, I-00161 Rome, Italy
来源
ANTIBIOTICS-BASEL | 2020年 / 9卷 / 06期
关键词
antibiotic resistance; plant secondary metabolites; plant-derived natural products; terpenes; diterpenes; triterpenes; multidrug-resistant strains; GRAM-NEGATIVE BACTERIA; METHICILLIN-RESISTANT; MULTIDRUG-RESISTANT; STAPHYLOCOCCUS-AUREUS; NATURAL-PRODUCTS; ANTIMICROBIAL RESISTANCE; POLYALTHIA-LONGIFOLIA; LABDANE DITERPENOIDS; CLERODANE DITERPENE; DRUG DISCOVERY;
D O I
10.3390/antibiotics9060325
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The discovery of antibiotics has revolutionized the medicine and treatment of microbial infections. However, the current scenario has highlighted the difficulties in marketing new antibiotics and an exponential increase in the appearance of resistant strains. On the other hand, research in the field of drug-discovery has revaluated the potential of natural products as a unique source for new biologically active molecules and scaffolds for the medicinal chemistry. In this review, we first contextualized the worldwide problem of antibiotic resistance and the importance that natural products of plant origin acquire as a source of new lead compounds. We then focused on terpenes and their potential development as antimicrobials, highlighting those studies that showed an activity against conventional antibiotic-resistant strains.
引用
收藏
页码:1 / 33
页数:34
相关论文
共 50 条
  • [41] Food-borne antibiotic-resistant Campylobacter infections
    不详
    NUTRITION REVIEWS, 1999, 57 (07) : 224 - 227
  • [42] Management of infections due to antibiotic-resistant Streptococcus pneumoniae
    Kaplan, SL
    Mason, EO
    CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (04) : 628 - +
  • [43] MICROBIOTA, PROBIOTICS AND THE FIGHT AGAINST ANTIBIOTIC-RESISTANT MICROORGANISMS: THE VETERINARY SIDE
    Perez Martinez, G.
    Requena, T.
    Sobrino, O. J.
    Rodriguez, J. M.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 22 - 29
  • [44] Antimicrobial Peptides, Their Production, and Potential in the Fight Against Antibiotic-Resistant Pathogens
    Saubenova, Margarita
    Rapoport, Alexander
    Yermekbay, Zhanerke
    Oleinikova, Yelena
    FERMENTATION-BASEL, 2025, 11 (01):
  • [45] Naturally-Occurring Alkaloids of Plant Origin as Potential Antimicrobials against Antibiotic-Resistant Infections
    Casciaro, Bruno
    Mangiardi, Laura
    Cappiello, Floriana
    Romeo, Isabella
    Loffredo, Maria Rosa
    Iazzetti, Antonia
    Calcaterra, Andrea
    Goggiamani, Antonella
    Ghirga, Francesca
    Mangoni, Maria Luisa
    Botta, Bruno
    Quaglio, Deborah
    MOLECULES, 2020, 25 (16):
  • [46] Activity of plant flavonoids against antibiotic-resistant bacteria
    Xu, HX
    Lee, SF
    PHYTOTHERAPY RESEARCH, 2001, 15 (01) : 39 - 43
  • [47] Plant-Derived Terpenoids: A Promising Tool in the Fight against Melanoma
    Klos, Patrycja
    Chlubek, Dariusz
    CANCERS, 2022, 14 (03)
  • [48] Therapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections
    Afacan, Nicole J.
    Yeung, Amy T. Y.
    Pena, Olga M.
    Hancock, Robert E. W.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (06) : 807 - 819
  • [49] URINARY TRACT INFECTIONS CAUSED BY ANTIBIOTIC-RESISTANT COLIFORM BACILLI
    KIRBY, WMM
    CORPRON, DO
    TANNER, DC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 162 (01): : 1 - 4
  • [50] Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host: An Update
    Dumford, Donald M.
    Skalweit, Marion J.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2020, 34 (04) : 821 - +